Jefferies Boosts Numbers On Medtronic (MDT) After Q3, Keeps Hold Rating

February 22, 2012 8:33 AM EST
Get Alerts MDT Hot Sheet
Price: $91.27 +0.76%

Rating Summary:
    25 Buy, 18 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Jefferies raised estimates and its price target on Medtronic, Inc. (NYSE: MDT) from $37 to $39, but kept its Hold rating following ho-hum Q3 results.

"The story remained the same for Medtronic in F3Q: weakness in ICDs and Spine continuing to weigh on the company’s growth profile and overshadowing a promising pipeline. While the shares currently trade at trough valuation and FCF remains robust, we see little basis for multiple expansion until and unless the growth profile improves."

The firm raised Q4 EPS from $0.97 to $0.98, FY12 was maintained at $3.45 and FY13 was raised from $3.66 to $3.69.

For an analyst ratings summary and ratings history on Medtronic, Inc. click here. For more ratings news on Medtronic, Inc. click here.

Shares of Medtronic, Inc. closed at $38.99 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

Jefferies & Co